Managing cardiovascular risk in patients with chronic inflammatory diseases

Area of Science:

• Cardiovascular Medicine
• Rheumatology
• Immunology

Background:

• Traditional cardiovascular disease (CVD) risk factors are well-established.
• The link between chronic inflammatory conditions and CVD risk is increasingly recognized.
• Pro-inflammatory cytokines are implicated in both atherosclerosis and chronic inflammatory diseases.

Purpose of the Study:

• To evaluate the extent of cardiovascular risk in common chronic inflammatory diseases.
• To determine if this risk stems from traditional factors or systemic inflammation.
• To review therapies impacting cardiovascular risk in these patients.

Main Methods:

• Systematic review of existing literature.
• Analysis of cardiovascular risk magnitude in chronic inflammatory diseases.
• Assessment of the contribution of systemic inflammation versus traditional risk factors.

Main Results:

• Patients with chronic inflammatory diseases face an underestimated increase in cardiovascular risk.
• Systemic inflammation appears to be an independent contributor to elevated CVD risk.
• Evidence suggests specific therapies can modify cardiovascular risk, both positively and negatively.

Conclusions:

• Chronic inflammatory diseases confer significant, often underestimated, cardiovascular risk.
• Individualized therapy is crucial, addressing inflammation, traditional risk factors, and comorbidities.
• Proactive patient management strategies are essential for high-risk individuals.